We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTN
4101
DELISTED
OptiNose
OPTN
$7.98K ﹤0.01%
364
-226
-38% -$5.02K
CNVS icon
4102
Cineverse
CNVS
$68.9M
$7.97K ﹤0.01%
5,738
+4,251
+286% +$6.11K
BTSG icon
4103
BrightSpring Health Services
BTSG
$11.8B
$7.97K ﹤0.01%
+733
New +$7.33K
BPTH
4104
DELISTED
Bio-Path Holdings Inc
BPTH
$7.97K ﹤0.01%
1,934
+1,448
+298% +$10.9K
SBGI icon
4105
Sinclair Inc
SBGI
$1B
$7.96K ﹤0.01%
591
-7,722
-93% -$110K
BTBD icon
4106
BT Brands
BTBD
$7.79M
$7.96K ﹤0.01%
4,824
-2,071
-30% -$4.12K
SBEV icon
4107
Splash Beverage Group
SBEV
$2.48M
$7.96K ﹤0.01%
108
-10
-8% -$797
LXEO icon
4108
Lexeo Therapeutics
LXEO
$400M
$7.95K ﹤0.01%
507
-983
-66% -$15.4K
SABR icon
4109
Sabre
SABR
$831M
$7.95K ﹤0.01%
3,284
-84,141
-96% -$282K
BIOR
4110
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$7.94K ﹤0.01%
722
-1
-0.1% -$11
PIK
4111
DELISTED
Kidpik Corp. Common Stock
PIK
$7.94K ﹤0.01%
1,737
-361
-17% -$872
CMRE icon
4112
Costamare
CMRE
$1.71B
$7.93K ﹤0.01%
699
-12,770
-95% -$141K
BHR
4113
Braemar Hotels & Resorts
BHR
$139M
$7.91K ﹤0.01%
3,957
-315
-7% -$696
MTNB icon
4114
Matinas BioPharma
MTNB
$1.49M
$7.91K ﹤0.01%
584
-214
-27% -$2.54K
LAND
4115
Gladstone Land Corp
LAND
$353M
$7.91K ﹤0.01%
593
-10,231
-95% -$138K
ARKR icon
4116
Ark Restaurants
ARKR
$20.2M
$7.91K ﹤0.01%
575
-287
-33% -$4.09K
PMVP icon
4117
PMV Pharmaceuticals
PMVP
$67.2M
$7.9K ﹤0.01%
4,646
-4,862
-51% -$9.08K
PPIH
4118
Perma-Pipe International
PPIH
$216M
$7.89K ﹤0.01%
999
-87
-8% -$703
NTGR icon
4119
NETGEAR
NTGR
$658M
$7.88K ﹤0.01%
500
-6,342
-93% -$92.3K
ATRI
4120
DELISTED
Atrion Corp
ATRI
$7.88K ﹤0.01%
17
-253
-94% -$94.9K
CFSB
4121
DELISTED
CFSB Bancorp
CFSB
$7.87K ﹤0.01%
1,086
+100
+10% +$734
TWOU
4122
DELISTED
2U Inc
TWOU
$7.86K ﹤0.01%
672
-437
-39% -$8.5K
ALGS icon
4123
Aligos Therapeutics
ALGS
$43.7M
$7.86K ﹤0.01%
321
-428
-57% -$8.52K
HYFM icon
4124
Hydrofarm Holdings
HYFM
$8.58M
$7.86K ﹤0.01%
728
-204
-22% -$1.86K
STHO icon
4125
Star Holdings Shares of Beneficial Interest
STHO
$117M
$7.83K ﹤0.01%
606
-2,412
-80% -$30.2K

Similar funds

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.